CSX vs IRD · P/E 19, rev $14.09B vs rev $11.0M
CSX Corporation (CSX) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
CSX Corporation (CSX) is a railroads company listed on US.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported CSX revenue for 2025-12-31 was $14.09B. Net income was $2.89B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
CSX currently screens at market cap $61.18B and trailing P/E 19.4. IRD currently screens at market cap $35.7M.
Not investment advice. Open the CSX and IRD stock pages for the full models.
Not investment advice.